Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

A study published in The Lancet confirms the one-shot Sputnik Light vaccine has a high safety profile and induces a strong humoral and cellular immune response both in the seronegative and seropositive groups

Press release, 03.11.2021

A study in the city of Buenos Aires confirms high efficacy of the Sputnik V in protecting individuals aged 60+

Press release, 01.11.2021

Sputnik V and Sputnik Light vaccines authorized in Cambodia

Press release, 31.10.2021

Individuals vaccinated with Sputnik V in Argentina are now eligible to enter EU

Press release, 29.10.2021

Israel joins 100 other countries in accepting the Sputnik V vaccine

Press release, 28.10.2021

GL Rapha becomes the first international partner of RDIF to obtain Russian GMP Certificate for Sputnik family vaccine production in Korea

Press release, 25.10.2021

On information attacks against Sputnik V vaccine

Press release, 21.10.2021

Approval of mixing and matching of COVID booster shots by FDA is yet another confirmation of efficacy of vaccine cocktail approach pioneered by the Russian Sputnik V vaccine

Press release, 21.10.2021

Fortune - Russia has big plans for the Sputnik vaccine, and big warnings for ‘the Big Pharma lobby’: cut out the attacks

Press release, 15.10.2021

Interim results of a pioneering combination study in Argentina with more than 1,000 participants confirm the one-shot Sputnik Light vaccine (the first component of the Sputnik V vaccine) is an effective universal booster for vaccines produced by AstraZeneca, Sinopharm, Moderna and Cansino inducing strong immune response and showing high safety profile. Combination of AstraZeneca and Sputnik Light vaccines showed high immunogenicity results

Press release, 14.10.2021

2 3 4 5 6